VITASPRING BIOMEDICAL CO., LTD. (VSBC) Financial Statements
VITASPRING BIOMEDICAL CO., LTD. (VSBC) files with the U.S. Securities and Exchange Commission under CIK 0001697884. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2026
- Revenue
- $0
- Net Income
- -$415.37 thousand
- Total Assets
- $14.68 thousand
- Net Cash from Operations
- -$2.69 thousand
Fiscal year ended Jan 31, 2026. Latest periodic SEC filing: Sep 17, 2026. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for VSBC in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History